Portfolio Monitoring for VCs: A Practical Guide to the Vital Signs That Matter

Portfolio monitoring is the practice of watching a small set of financial vital signs across every company a fund backs, so the fund can act while there is still time. It is not a 40-column report nobody reads. It is the line on the screen that, when it drops, tells you to move now.

Picture the doctor in an intensive care ward. She does not gaze anxiously at the whole patient. She watches the monitor on the wall, and she knows precisely which jagged line, when it suddenly falls, means move now. That is the model, plainly. A fund with a healthy portfolio and a fund harbouring a quietly dying company look identical from across the noisy room. The screen is how you tell them apart.

What portfolio monitoring actually is

A KPI, a key performance indicator, is a measurable signal of whether a company is moving toward its goals. Portfolio monitoring applies the same idea across a portfolio: a fund tracks the indicators that matter for each company it backed, then reads them together.

The vanity version tracks everything. Forty metrics, gathered by analysts, assembled into a quarterly report, read by no one, obsolete on arrival. Tracking 40 metrics is not rigor. It is noise. The patient is wired to so many screens that the one line that matters is buried alive.

The disciplined version does the precise opposite. It watches a tiny handful of vital signs, relentlessly, obsessively, the way a doctor watches blood pressure and heart rate instead of fussing over every twitching cell in the body. Fewer lines, watched live, comfortably beat a sprawling report nobody ever opens.

The five vital signs that matter

A patient in critical care is watched through a few readings that fail fast and fail loud. A portfolio company has its own. Watch these five.

Cash. The balance in the account. Everything else is merely a story about cash. When cash hits zero the company dies, full stop, and no clever metric saves it. This is the heartbeat. Lose it and the rest is academic.

Burn. How fast the company spends in a month. A high burn is not always sickly and a low burn is not always healthy, but burn read against cash tells you how much time is left. Burn is the line you scrutinise in the same breath as cash, never apart from it.

The burn multiple. How much a company spends to add a dollar of new revenue. A low multiple means the spend is working. A high one means the company is recklessly buying growth it cannot afford. This is the reading that separates a strong company from one merely wearing the costume of strength.

Net revenue retention. How much money existing customers spend this year against last year, after churn. Gross retention tells you who walked out the door. Net retention tells you whether the ones who stayed are growing. A company can post dazzling top-line growth while net retention quietly rots underneath. That is a fever the glossy headline number hides.

Time. Cash divided by burn. The number of months the company can survive before it needs more money or a profit. Every other vital sign quietly feeds this one. When time runs alarmingly short, the patient is no longer stable, and the fund faces a decision.

When to act, and the edge it buys

Here is where monitoring earns its keep. The point of watching the screen is not to admire it. It is to act early, while there is still room to react.

A fund that reads its vital signs live strolls calmly into a board meeting already knowing the answer. That is the edge. Awareness, sensed early, is a weapon. Call it the GP’s saber: the sharp, unhurried discipline that lets you move gracefully before the company begs for help, not after. The investor with the best data, not the loudest opinion, commands the room. Fear of the ugly news only holds power over the investor who learns it dead last.

Most funds learn it last. They monitor on a sleepy quarterly cadence, so the report thudding onto the desk in May describes a company that no longer exists. A burn multiple read once a quarter is read three months late. By then the patient has lurched from stable to critical and the fund finds out at the funeral. Live beats quarterly the way a heart monitor beats a yearly check.

This is also where reserves get decided. A fund has finite money to funnel back into its winners and its strugglers. Monitoring is how it knows which company is three months from zero. Send the money to the company that can be saved, while it can still be saved. That decision is only as good as the vital signs behind it.

Building the monitor on the wall

You do not need 40 lines. You need five, fed by connected data, read continuously instead of assembled by hand once a quarter. The discipline is in the watching, not the gathering.

Start with cash and burn, because they answer the only question that ends a company. Add the burn multiple and net revenue retention to tell strong growth from expensive growth. Add time to tie them together. Then connect the feed so the numbers flow on their own, the way a monitor reads a patient without a doctor copying figures by hand.

CX Cash exists to be that monitor on the wall. It pulls a portfolio’s cash data into one live view, so a fund watches the few vital signs that matter across every company at once and acts in time. You should know where the money is going, for every company you back, before the board meeting and not after.

Frequently asked questions

What is portfolio monitoring in venture capital?

Portfolio monitoring is how a venture fund tracks the financial health of every company it backed, by watching a small set of vital signs like cash, burn, and revenue retention. The goal is to act early, while a weak company can still be saved and a strong one still backed.

Which metrics matter most for portfolio monitoring?

Five vital signs cover most of it: cash, burn, the burn multiple, net revenue retention, and time, which is cash divided by burn. Cash and burn answer whether the company survives. The burn multiple and net retention tell strong growth from expensive growth. Time ties them together.

How often should a fund monitor its portfolio?

As live as the data allows. A quarterly report describes a company as it was three months ago, by which point a fast-burning company may already be critical. Connected, continuous data lets a fund read its vital signs the way a doctor reads a monitor.

How is portfolio monitoring different from due diligence?

Due diligence happens before the money goes in. It is the deep one-time review of a company you might back. Portfolio monitoring happens after, continuously, watching the vital signs of a company you already own. One decides whether to invest. The other decides what to do next. Both share one goal: never being the last to know.

The stand

Tracking 40 metrics is not monitoring. It is theater, pure and expensive. Five vital signs, watched live, demolish a 40-column report every time, because the doctor who anxiously watches the whole patient sees nothing useful and the one who watches the monitor moves in time.

Pick your five. Connect the feed. Read it like the glowing line on the wall it is. If you want the head start, join CX Cash for early access, grab the due-diligence and KPI guide, and gleefully forward this to the partner still squinting at the quarterly report in May. You should know where the money is going.